Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. (Q38929849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

27 February 2020

main subject

0 references

author

Miguel Viveiros

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Diana Machado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

E Cambau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

L Raskine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

C Ritter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

E Tortoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

V Matthys

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Hoffner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

E Richter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

M L Perez Del Molino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

D M Cirillo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

D van Soolingen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

E C Böttger

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

11 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

27 February 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

686-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587993%20AND%20SRC:MED&resulttype=core&format=json

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Improved outcomes for patients with multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibili

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

The ins and outs of Mycobacterium tuberculosis drug susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Synthetic EthR inhibitors boost antituberculous activity of ethionamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

Delamanid for multidrug-resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU438